The series E round included existing investors Qualcomm and Hearst Health Ventures, and was closed together with a $13m debt facility from Silicon Valley Bank.

The gastric balloon developer has gone public, after raising more than $70m in debt and equity from investors including Bader Sultan & Bros and AmorePacific.

Venture firm Medicxi is investing $11.2m in Kymo Therapeutics, a startup launched by biotech company Metabrain Research to advance its kynurenine metabolism inhibitor research.

Blue Cross and Blue Shield Association-backed home palliative care provider Aspire Health has now raised more than $57m altogether, after completing a GV-led funding round.

Lower limb ulcer treatment developer Ilkos Therapeutics has been set up with $21m in capital from investors including strategic partner Servier.

Cambridge Enterprise Seed Funds and Cambridge Innovation Capital have invested in Carrick Therapeutics, a company commercialising research from Cambridge and Oxford universities and Imperial College London.

KU Leuven's Centre for Drug Design and Discovery has closed a $67.5m commercialization fund with the support of the European Investment Fund.

Evotec and GV have invested in Carrick Therapeutics, a company commercialising research from institutions including Cambridge and Oxford universities and Imperial College London.